Scientists participating in the NIMH-sponsored MATRICS project ranked these
molecular targets as the nine most promising targets for development of
a drug to treat cognitive impairments in schizophrenia. The nine molecular
targets are implicated in seven domains of cognition: working memory,
attention/vigilance, verbal learning and memory, visual learning and memory,
speed of processing, reasoning and problem-solving, and social cognition.